Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous butylscopolamine vs placebo for death rattle control in the agony phase
2014-000779-26Phase 3Terminated
- Sponsor
- Biogipuzkoa Health Research Institute
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Terminal phase of disease comparing Buscopan with Placebo (2 arms). Primary endpoints: Control of death rattle and Prevention of death rattle. Started Jul 2014; status: terminated.
02
Drugs
hyoscine butylbromide
03
Conditions
Terminal phase of disease
Beyond the preview
Go deeper on 2014-000779-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000779-26.